JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lowenthal, J.
Right arrow Articles by MacFarlane, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lowenthal, J.
Right arrow Articles by MacFarlane, J. A.
Journal of Pharmacology And Experimental Therapeutics, Vol. 147, Issue 1, 130-138, 1965
Copyright © 1965 by American Society for Pharmacology and Experimental Therapeutics


VITAMIN K-LIKE AND ANTIVITAMIN K ACTIVITY OF SUBSTITUTED PARA-BENZOQUINONES

Julius Lowenthal 1 and J. A. MacFarlane 1

1 Department of Pharmacology and Therapeutics, University of Manitoba Faculty of Medicine, Winnipeg, Canada

Suitably substituted para-benzoquinones can show vitamin K-like or antivitamin K activity. The type of activity depends on the nature and position of the substituents.

The benzoquinone analogue of vitamin K1, 2,5,6-trimethyl-3-phytyl-1,4-benzoquinone, shows low vitamin K-like activity and acts as a partial agonist of vitamin K1.

Replacement of the methyl group in the 2-position by a chlorine on bromine atom results in antivitamin K activity, while replacement by a hydrogen atom or methoxy group gives compounds without vitamin K-like or antivitamin K activity.

The methyl groups in the 5- and 6-position are necessary for both vitamin K-like and antivitamin K activity. Replacement of the methyl groups in these positions by a chlorine atom or methoxy group results in loss of either activity.

Replacement of the phytyl side chain in the 3-position by shorter polyisoprenoid side chains in compounds with vitamin K-like or antivitamin K activity also results in loss of either activity.

Accepted on October 5, 1964







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1965 by the American Society for Pharmacology and Experimental Therapeutics.